Search by Drug Name or NDC

NDC 42192-0343-30 Prenaissance Plus 30; 100; 400; 250; 50; 1; 28; 25 [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1 Details

Prenaissance Plus 30; 100; 400; 250; 50; 1; 28; 25 [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1

Prenaissance Plus is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Acella Pharmaceuticals, LLC. The primary component is .ALPHA.-TOCOPHEROL ACETATE, DL-; CALCIUM CITRATE; CHOLECALCIFEROL; DOCONEXENT; DOCUSATE SODIUM; FOLIC ACID; IRON PENTACARBONYL; PYRIDOXINE HYDROCHLORIDE.

Product Information

NDC	42192-0343
Product ID	42192-343_c16d9980-89fc-43da-938b-f725e2ec89a0
Associated GPIs	78516035000130
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Prenaissance Plus
Proprietary Name Suffix	n/a
Non-Proprietary Name	CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, DOCUSATE SODIUM and DOCONEXENT
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE, LIQUID FILLED
Route	ORAL
Active Ingredient Strength	30; 100; 400; 250; 50; 1; 28; 25
Active Ingredient Units	[iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1
Substance Name	.ALPHA.-TOCOPHEROL ACETATE, DL-; CALCIUM CITRATE; CHOLECALCIFEROL; DOCONEXENT; DOCUSATE SODIUM; FOLIC ACID; IRON PENTACARBONYL; PYRIDOXINE HYDROCHLORIDE
Labeler Name	Acella Pharmaceuticals, LLC
Pharmaceutical Class	Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin D [CS], Vitamin D [EPC]
DEA Schedule	n/a
Marketing Category	UNAPPROVED DRUG OTHER
Application Number	n/a
Listing Certified Through	2022-12-31

Package

Package Images

NDC 42192-0343-30 (42192034330)

Pricing Information	N/A
NDC Package Code	42192-343-30
Billing NDC	42192034330
Package	30 CAPSULE, LIQUID FILLED in 1 CAPSULE (42192-343-30)
Marketing Start Date	2011-10-07
NDC Exclude Flag	N

Standard Product Labeling (SPL)/Prescribing Information SPL 1459ccd1-2372-450f-ac17-382ca9a5b175 Details

SPL UNCLASSIFIED SECTION

Rx Only

DESCRIPTION:

Prenaissance Plus is a prescription prenatal/postnatal multivitamin/multimineral softgel capsule with DHA. Each softgel is purple in color, opaque and imprinted with "343" on one side.

EACH SOFTGEL CONTAINS:

Calcium (Calcium citrate)	100 mg
Iron (Carbonyl Iron)	28 mg
Vitamin D3 (Cholecalciferol)	400 IU
Vitamin E (dl-alpha tocopherol acetate)	30 IU
Vitamin B6 (Pyridoxine HCI)	25 mg
Folic Acid	1 mg
Docusate Sodium	50 mg
DHA (Docosahexaenoic acid)	250 mg

OTHER INGREDIENTS:

soybean oil, yellow bee's wax, lecithin, natural orange cream flavoring, gelatin, glycerine, purified water, carmine, titanium dioxide, ethyl vanillin, FD&C#40, and FD&C Blue #1.

INDICATIONS:

Prenaissance Plus is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

CONTRAINDICATIONS:

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING:

Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

WARNING

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS:

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

ADVERSE REACTIONS:

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

CAUTION:

Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) daily.

DOSAGE AND ADMINISTRATION:

Usual adult dose is 1 (one) softgel daily or as directed by a physician.

NOTICE:

Contact the moisture can discolor or erode the capsule.

HOW SUPPLIED:

Prenaissance Plus is supplied in child-resistant bottles of 30 softgels (NDC# 42192-343-30).

Store at 15° - 30°C (59° - 86°F) [See USP].

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

SPL UNCLASSIFIED SECTION

All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. Please note: this is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical information provided herein.

MANUFACTURED FOR:

Acella Pharmaceuticals, LLC

Alpharetta, GA 30009

PRINCIPAL DISPLAY PANEL - 30 Softgels

NDC 42192-343-30

Prenaissance Plus

Rx Prenatal Vitamin and DHA

Rx only 30 Softgels

Acella

PHARMACEUTICALS, LLC

INGREDIENTS AND APPEARANCE

PRENAISSANCE PLUS

calcium citrate, iron pentacarbonyl, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine hydrochloride, folic acid, docusate sodium and doconexent capsule, liquid filled

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC:42192-343
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CALCIUM CITRATE (UNII: MLM29U2X85) (CALCIUM CATION - UNII:2M83C4R6ZB)	CALCIUM CITRATE ANHYDROUS	100 mg
IRON PENTACARBONYL (UNII: 6WQ62TAQ6Z) (FERROUS CATION - UNII:GW89581OWR)	FERROUS CATION	28 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41)	CHOLECALCIFEROL	400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01)	.ALPHA.-TOCOPHEROL, DL-	30 [iU]
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z)	PYRIDOXINE	25 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)	FOLIC ACID	1 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)	DOCUSATE SODIUM	50 mg
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC)	DOCONEXENT	250 mg

Ingredient Name	Strength
Inactive Ingredients
SOYBEAN OIL (UNII: 241ATL177A)
YELLOW WAX (UNII: 2ZA36H0S2V)
GELATIN (UNII: 2G86QN327L)
GLYCERIN (UNII: PDC6A3C0OX)
WATER (UNII: 059QF0KO0R)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
ETHYL VANILLIN (UNII: YC9ST449YJ)
FD&C RED NO. 40 (UNII: WZB9127XOA)
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)

Product Characteristics
Color	PURPLE	Score	no score
Shape	CAPSULE	Size	25mm
Flavor		Imprint Code	343
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:42192-343-30	30 in 1 CAPSULE; Type 0: Not a Combination Product	10/07/2011

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
UNAPPROVED DRUG OTHER		10/07/2011

Labeler - Acella Pharmaceuticals, LLC (825380939)

Registrant - Acella Pharmaceuticals, LLC (825380939)

Name	Address	ID/FEI	Business Operations
Establishment
Acella Pharmaceuticals, LLC		825380939	manufacture(42192-343)

Revised: 9/2018

Document Id: c16d9980-89fc-43da-938b-f725e2ec89a0

Set id: 1459ccd1-2372-450f-ac17-382ca9a5b175

Version: 5

Effective Time: 20180912

Search by Drug Name or NDC

NDC 42192-0343-30 Prenaissance Plus 30; 100; 400; 250; 50; 1; 28; 25 [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1 Details

Prenaissance Plus 30; 100; 400; 250; 50; 1; 28; 25 [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1

Product Information

Package

Package Images

NDC 42192-0343-30 (42192034330)

Contents

Standard Product Labeling (SPL)/Prescribing Information SPL 1459ccd1-2372-450f-ac17-382ca9a5b175 Details

SPL UNCLASSIFIED SECTION

DESCRIPTION:

OTHER INGREDIENTS:

INDICATIONS:

CONTRAINDICATIONS:

WARNING:

WARNING

PRECAUTIONS:

ADVERSE REACTIONS:

CAUTION:

DOSAGE AND ADMINISTRATION:

NOTICE:

HOW SUPPLIED:

SPL UNCLASSIFIED SECTION

PRINCIPAL DISPLAY PANEL - 30 Softgels

INGREDIENTS AND APPEARANCE

Questions About Combining Hydroxyzine And Buspirone

Can You Take A Z-Pak If You Have A Penicillin Allergy?